Cargando…

Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2

The effective reproductive number R(e) is a key indicator of the growth of an epidemic. Since the start of the SARS-CoV-2 pandemic, many methods and online dashboards have sprung up to monitor this number through time. However, these methods are not always thoroughly tested, correctly placed in time...

Descripción completa

Detalles Bibliográficos
Autores principales: Huisman, Jana S, Scire, Jérémie, Angst, Daniel C, Li, Jinzhou, Neher, Richard A, Maathuis, Marloes H, Bonhoeffer, Sebastian, Stadler, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467515/
https://www.ncbi.nlm.nih.gov/pubmed/35938911
http://dx.doi.org/10.7554/eLife.71345
_version_ 1784788209541054464
author Huisman, Jana S
Scire, Jérémie
Angst, Daniel C
Li, Jinzhou
Neher, Richard A
Maathuis, Marloes H
Bonhoeffer, Sebastian
Stadler, Tanja
author_facet Huisman, Jana S
Scire, Jérémie
Angst, Daniel C
Li, Jinzhou
Neher, Richard A
Maathuis, Marloes H
Bonhoeffer, Sebastian
Stadler, Tanja
author_sort Huisman, Jana S
collection PubMed
description The effective reproductive number R(e) is a key indicator of the growth of an epidemic. Since the start of the SARS-CoV-2 pandemic, many methods and online dashboards have sprung up to monitor this number through time. However, these methods are not always thoroughly tested, correctly placed in time, or are overly confident during high incidence periods. Here, we present a method for timely estimation of R(e), applied to COVID-19 epidemic data from 170 countries. We thoroughly evaluate the method on simulated data, and present an intuitive web interface for interactive data exploration. We show that, in early 2020, in the majority of countries the estimated R(e) dropped below 1 only after the introduction of major non-pharmaceutical interventions. For Europe the implementation of non-pharmaceutical interventions was broadly associated with reductions in the estimated R(e). Globally though, relaxing non-pharmaceutical interventions had more varied effects on subsequent R(e) estimates. Our framework is useful to inform governments and the general public on the status of epidemics in their country, and is used as the official source of R(e) estimates for SARS-CoV-2 in Switzerland. It further allows detailed comparison between countries and in relation to covariates such as implemented public health policies, mobility, behaviour, or weather data.
format Online
Article
Text
id pubmed-9467515
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-94675152022-09-13 Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2 Huisman, Jana S Scire, Jérémie Angst, Daniel C Li, Jinzhou Neher, Richard A Maathuis, Marloes H Bonhoeffer, Sebastian Stadler, Tanja eLife Epidemiology and Global Health The effective reproductive number R(e) is a key indicator of the growth of an epidemic. Since the start of the SARS-CoV-2 pandemic, many methods and online dashboards have sprung up to monitor this number through time. However, these methods are not always thoroughly tested, correctly placed in time, or are overly confident during high incidence periods. Here, we present a method for timely estimation of R(e), applied to COVID-19 epidemic data from 170 countries. We thoroughly evaluate the method on simulated data, and present an intuitive web interface for interactive data exploration. We show that, in early 2020, in the majority of countries the estimated R(e) dropped below 1 only after the introduction of major non-pharmaceutical interventions. For Europe the implementation of non-pharmaceutical interventions was broadly associated with reductions in the estimated R(e). Globally though, relaxing non-pharmaceutical interventions had more varied effects on subsequent R(e) estimates. Our framework is useful to inform governments and the general public on the status of epidemics in their country, and is used as the official source of R(e) estimates for SARS-CoV-2 in Switzerland. It further allows detailed comparison between countries and in relation to covariates such as implemented public health policies, mobility, behaviour, or weather data. eLife Sciences Publications, Ltd 2022-08-08 /pmc/articles/PMC9467515/ /pubmed/35938911 http://dx.doi.org/10.7554/eLife.71345 Text en © 2022, Huisman, Scire et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Epidemiology and Global Health
Huisman, Jana S
Scire, Jérémie
Angst, Daniel C
Li, Jinzhou
Neher, Richard A
Maathuis, Marloes H
Bonhoeffer, Sebastian
Stadler, Tanja
Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
title Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
title_full Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
title_fullStr Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
title_full_unstemmed Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
title_short Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2
title_sort estimation and worldwide monitoring of the effective reproductive number of sars-cov-2
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467515/
https://www.ncbi.nlm.nih.gov/pubmed/35938911
http://dx.doi.org/10.7554/eLife.71345
work_keys_str_mv AT huismanjanas estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT scirejeremie estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT angstdanielc estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT lijinzhou estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT neherricharda estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT maathuismarloesh estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT bonhoeffersebastian estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2
AT stadlertanja estimationandworldwidemonitoringoftheeffectivereproductivenumberofsarscov2